Skip to main content
BNGO logo
BNGO
(NASDAQ)
Bionano Genomics, Inc.
$1.16-- (--)
Loading... - Market loading

Bionano Genomics (BNGO) Stock Price & Financial Analysis

Bionano Genomics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.16 - $1.19
52-Week High$5.50
52-Week Low$1.06
Open$1.18
Volume83.36K
Average Volume (3M)169.87K
Market Cap6.32M
Shares Outstanding5.45M
Price to Sales (P/S)0.22
Price to Book (P/B)0.14
EV/EBITDA-0.45
Revenue (TTM)28.51M
Net Income (TTM)-26.39M
Free Cash Flow (TTM)-16.34M
EPS (TTM)$-4.75
Profit Margin-92.59%
Operating Margin-116.95%
Return on Equity (ROE)-59.42%
Debt to Equity0.16
50-Day MA$1.22
200-Day MA$1.62
52-Week Change-67.57%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Bionano Genomics

What is the current stock price for BNGO?

As of the latest trading session, BNGO stock trades at $1.16. The 52-week range is $1.06–$5.50, with a day range of $1.16–$1.19.

What is the P/E ratio for BNGO?

The P/E ratio (Price-to-Earnings) for BNGO is shown in the Key Statistics section. This valuation metric helps compare Bionano Genomics, Inc. to industry peers.

Does BNGO pay dividends?

Bionano Genomics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BNGO?

Based on 1 analyst, the consensus for BNGO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BNGO?

Bionano Genomics's market capitalization is $6.3M, classifying it as a micro-cap company. Bionano Genomics operates in the Healthcare sector within the Medical Instruments & Supplies industry.